MWA
ABBV icon

Motive Wealth Advisors’s AbbVie ABBV Stock Holding History

Motive Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$551K Sell
2,188
-14
-0.6% -$3.01K 0.23% 50
2026
Q1 		$479K Buy
2,202
+8
+0.4% +$1.77K 0.22% 49
2025
Q4 		$501K Buy
2,194
+2
+0.1% +$456 0.21% 46
2025
Q3 		$508K Buy
2,192
+21
+1% +$4.28K 0.22% 46
2025
Q2 		$403K Buy
2,171
+194
+10% +$36.1K 0.18% 49
2025
Q1 		$414K Sell
1,977
-17
-0.9% -$3.31K 0.22% 47
2024
Q4 		$354K Buy
1,994
+165
+9% +$30.3K 0.19% 54
2024
Q3 		$314K Hold
1,829
– – 0.19% 50
2024
Q2 		$314K Sell
1,829
-41
-2% -$6.79K 0.19% 50
2024
Q1 		$341K Buy
+1,870
New +$322K 0.21% 52
2023
Q4 		– Sell
-1,481
Closed -$221K – 44
2023
Q3 		$221K Sell
1,481
-124
-8% -$18.2K 0.24% 48
2023
Q2 		$216K Sell
1,605
-62
-4% -$9.09K 0.22% 52
2023
Q1 		$266K Sell
1,667
-431
-21% -$65.9K 0.29% 43
2022
Q4 		$339K Buy
2,098
+586
+39% +$89.9K 0.26% 42
2022
Q3 		$203K Buy
+1,512
New +$217K 0.16% 60

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Motive Wealth Advisors's ABBV Position: Q2 2026 in Review

Motive Wealth Advisors reduced its AbbVie (ABBV) stake by 0.64% in Q2 2026, selling an estimated $3.01K and leaving 2,188 shares worth $551K. The position accounts for 0.23% of the portfolio, ranked #50.

Motive Wealth Advisors first reported a position in ABBV in Q3 2022 and has held it in 15 quarters since. 1,061 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Motive Wealth Advisors held 2,188 shares of AbbVie worth $551K as of Q2 2026.
  • Motive Wealth Advisors sold 14 AbbVie shares in Q2 2026, an estimated $3.01K.
  • AbbVie made up 0.23% of Motive Wealth Advisors's portfolio in Q2 2026, its #50 holding.
  • Motive Wealth Advisors first reported a position in AbbVie in Q3 2022 and has held it in 15 quarters since.
  • 1,061 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Motive Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.